1. Home
  2. ECPG vs OCUL Comparison

ECPG vs OCUL Comparison

Compare ECPG & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Encore Capital Group Inc

ECPG

Encore Capital Group Inc

HOLD

Current Price

$82.42

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$9.26

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECPG
OCUL
Founded
1998
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
ECPG
OCUL
Price
$82.42
$9.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
9
Target Price
$77.33
$23.56
AVG Volume (30 Days)
293.7K
2.6M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
287.14
N/A
EPS
3.86
N/A
Revenue
$1,768,802,000.00
$1,990,000.00
Revenue This Year
$4.53
$7.93
Revenue Next Year
$4.76
$96.07
P/E Ratio
$21.74
N/A
Revenue Growth
34.37
3.48
52 Week Low
$35.68
$6.23
52 Week High
$92.64
$16.44

Technical Indicators

Market Signals
Indicator
ECPG
OCUL
Relative Strength Index (RSI) 60.69 48.53
Support Level $54.39 $9.06
Resistance Level $85.42 $9.91
Average True Range (ATR) 3.21 0.42
MACD -0.52 -0.02
Stochastic Oscillator 29.55 15.30

Price Performance

Historical Comparison
ECPG
OCUL

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company engaged in providing debt recovery solutions and other related services for consumers across a broad range of financial assets. It mainly purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals to repay their obligations and work toward financial recovery. The company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe. It has only one reportable segment, debt purchasing and recovery. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Europe, and other regions.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: